Polling data released this week shows that nearly 90% of Republican voters support allowing Medicare to negotiate drug prices directly with pharmaceutical companies. But congressional Republicans — many of whom receive substantial funding from the pharmaceutical industry — have staked out the opposite position, bashing the Biden administration’s rollout of the initial list of medications that will…
BROADCASTING FOR INDEPENDENCE
